Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...

A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not ...

As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their own GLP-1 journeys and explores how decades of diet culture and society’s relentless pursuit of ...

有业内人士在会上透露，除2型糖尿病和减重适应症外，多种适应症正在开发中，未来或将拓展至PCOS（多囊卵巢综合症）、脑卒中等领域。此外GLP（胰高糖素样肽-1），GIP（葡萄糖依赖性促胰岛素释放肽），GCG（胰高血糖素）三靶点药物开始崛起，多靶点联合作用或将达到治疗代谢疾病的最佳疗效。

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Tennessee's Medicaid program, TennCare, covers drugs like Ozempic and Mounjaro to treat those with diabetes and heart ...

国内方面，华东医药利拉鲁肽注射液肥胖或体重超重适应证于去年7月获批，是国内首个获批上市的利拉鲁肽生物类似药。这一重磅消息，让GLP-1药物进入大众视野，自此减肥药概念在二级市场上风生水起。今年年初春节档电影《热辣滚烫》再度点燃减肥市场的激情。时至今日 ...

Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

An estimated one in ten Americans have been on a GLP-1. Some 12% — or about 1 in 8 — people living in the U.S. have tried a GLP-1 drug, according to a survey by the Kaiser Family Foundation. And with ...

The holidays are near, and so is the season of eating decadent meals – and sometimes, overeating. Overindulging on food is ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...